Sheldon L. Koenig - 17 Mar 2022 Form 4 Insider Report for Esperion Therapeutics, Inc. (ESPR)

Role
President and CEO, Director
Signature
/s/ Richard B. Bartram, by power of attorney
Issuer symbol
ESPR
Transactions as of
17 Mar 2022
Net transactions value
-$2,615
Form type
4
Filing time
18 Mar 2022, 16:29:50 UTC
Previous filing
16 Mar 2022
Next filing
09 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ESPR Common Stock Sale $2,615 -571 -0.29% $4.58 194,717 17 Mar 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold to satisfy tax obligation on quarterly vested shares of restricted stock units.